Comparison of high-performance liquid chromatographic and microbiological methods for determination of voriconazole levels in plasma

Sofia Perea, Gennethel J. Pennick, Asha Modak, Annette W. Fothergill, Deanna A. Sutton, Daniel J. Sheehan, Michael G. Rinaldi

Research output: Contribution to journalArticle

91 Citations (Scopus)

Abstract

A new selective high-performance liquid chromatography (HPLC) method with UV detection for the determination of the investigational triazole voriconazole in human plasma by using acetonitrile precipitation followed by reverse-phase HPLC on a C18 column was compared with a simple agar well diffusion bioassay method with Candida kefyr ATCC 46764 as the assay organism. Pooled plasma was used to prepare standard and control samples for both methods. The results of analyses with spiked serum samples (run as unknowns) were concordant by the bioassay and HPLC methods, with expected values being obtained. HPLC demonstrated an improved precision (3.47 versus 12.12%) and accuracy (0.81 versus 1.28%) compared to those of the bioassay method. The range of linearity obtained by both methods (from 0.2 to 10 μg/ml for HPLC and from 0.25 to 20 μg/ml for the bioassay) includes the range of concentrations of voriconazole (from 1.2 to 4.7 μg/ml) which are considered clinically relevant. Although either methodology could be used for the monitoring of patient therapy, the smaller variability, observed with HPLC compared to that observed with the bioassay favors the use of HPLC for pharmacokinetic studies.

Original languageEnglish (US)
Pages (from-to)1209-1213
Number of pages5
JournalAntimicrobial Agents and Chemotherapy
Volume44
Issue number5
DOIs
StatePublished - May 2000

Fingerprint

High Pressure Liquid Chromatography
Biological Assay
Triazoles
Physiologic Monitoring
Reverse-Phase Chromatography
Voriconazole
Candida
Agar
Pharmacokinetics
Serum
Therapeutics

ASJC Scopus subject areas

  • Pharmacology (medical)

Cite this

Comparison of high-performance liquid chromatographic and microbiological methods for determination of voriconazole levels in plasma. / Perea, Sofia; Pennick, Gennethel J.; Modak, Asha; Fothergill, Annette W.; Sutton, Deanna A.; Sheehan, Daniel J.; Rinaldi, Michael G.

In: Antimicrobial Agents and Chemotherapy, Vol. 44, No. 5, 05.2000, p. 1209-1213.

Research output: Contribution to journalArticle

Perea, Sofia ; Pennick, Gennethel J. ; Modak, Asha ; Fothergill, Annette W. ; Sutton, Deanna A. ; Sheehan, Daniel J. ; Rinaldi, Michael G. / Comparison of high-performance liquid chromatographic and microbiological methods for determination of voriconazole levels in plasma. In: Antimicrobial Agents and Chemotherapy. 2000 ; Vol. 44, No. 5. pp. 1209-1213.
@article{ba309e443a804973b19f7a6a4afdbbda,
title = "Comparison of high-performance liquid chromatographic and microbiological methods for determination of voriconazole levels in plasma",
abstract = "A new selective high-performance liquid chromatography (HPLC) method with UV detection for the determination of the investigational triazole voriconazole in human plasma by using acetonitrile precipitation followed by reverse-phase HPLC on a C18 column was compared with a simple agar well diffusion bioassay method with Candida kefyr ATCC 46764 as the assay organism. Pooled plasma was used to prepare standard and control samples for both methods. The results of analyses with spiked serum samples (run as unknowns) were concordant by the bioassay and HPLC methods, with expected values being obtained. HPLC demonstrated an improved precision (3.47 versus 12.12{\%}) and accuracy (0.81 versus 1.28{\%}) compared to those of the bioassay method. The range of linearity obtained by both methods (from 0.2 to 10 μg/ml for HPLC and from 0.25 to 20 μg/ml for the bioassay) includes the range of concentrations of voriconazole (from 1.2 to 4.7 μg/ml) which are considered clinically relevant. Although either methodology could be used for the monitoring of patient therapy, the smaller variability, observed with HPLC compared to that observed with the bioassay favors the use of HPLC for pharmacokinetic studies.",
author = "Sofia Perea and Pennick, {Gennethel J.} and Asha Modak and Fothergill, {Annette W.} and Sutton, {Deanna A.} and Sheehan, {Daniel J.} and Rinaldi, {Michael G.}",
year = "2000",
month = "5",
doi = "10.1128/AAC.44.5.1209-1213.2000",
language = "English (US)",
volume = "44",
pages = "1209--1213",
journal = "Antimicrobial Agents and Chemotherapy",
issn = "0066-4804",
publisher = "American Society for Microbiology",
number = "5",

}

TY - JOUR

T1 - Comparison of high-performance liquid chromatographic and microbiological methods for determination of voriconazole levels in plasma

AU - Perea, Sofia

AU - Pennick, Gennethel J.

AU - Modak, Asha

AU - Fothergill, Annette W.

AU - Sutton, Deanna A.

AU - Sheehan, Daniel J.

AU - Rinaldi, Michael G.

PY - 2000/5

Y1 - 2000/5

N2 - A new selective high-performance liquid chromatography (HPLC) method with UV detection for the determination of the investigational triazole voriconazole in human plasma by using acetonitrile precipitation followed by reverse-phase HPLC on a C18 column was compared with a simple agar well diffusion bioassay method with Candida kefyr ATCC 46764 as the assay organism. Pooled plasma was used to prepare standard and control samples for both methods. The results of analyses with spiked serum samples (run as unknowns) were concordant by the bioassay and HPLC methods, with expected values being obtained. HPLC demonstrated an improved precision (3.47 versus 12.12%) and accuracy (0.81 versus 1.28%) compared to those of the bioassay method. The range of linearity obtained by both methods (from 0.2 to 10 μg/ml for HPLC and from 0.25 to 20 μg/ml for the bioassay) includes the range of concentrations of voriconazole (from 1.2 to 4.7 μg/ml) which are considered clinically relevant. Although either methodology could be used for the monitoring of patient therapy, the smaller variability, observed with HPLC compared to that observed with the bioassay favors the use of HPLC for pharmacokinetic studies.

AB - A new selective high-performance liquid chromatography (HPLC) method with UV detection for the determination of the investigational triazole voriconazole in human plasma by using acetonitrile precipitation followed by reverse-phase HPLC on a C18 column was compared with a simple agar well diffusion bioassay method with Candida kefyr ATCC 46764 as the assay organism. Pooled plasma was used to prepare standard and control samples for both methods. The results of analyses with spiked serum samples (run as unknowns) were concordant by the bioassay and HPLC methods, with expected values being obtained. HPLC demonstrated an improved precision (3.47 versus 12.12%) and accuracy (0.81 versus 1.28%) compared to those of the bioassay method. The range of linearity obtained by both methods (from 0.2 to 10 μg/ml for HPLC and from 0.25 to 20 μg/ml for the bioassay) includes the range of concentrations of voriconazole (from 1.2 to 4.7 μg/ml) which are considered clinically relevant. Although either methodology could be used for the monitoring of patient therapy, the smaller variability, observed with HPLC compared to that observed with the bioassay favors the use of HPLC for pharmacokinetic studies.

UR - http://www.scopus.com/inward/record.url?scp=0034007446&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034007446&partnerID=8YFLogxK

U2 - 10.1128/AAC.44.5.1209-1213.2000

DO - 10.1128/AAC.44.5.1209-1213.2000

M3 - Article

C2 - 10770753

AN - SCOPUS:0034007446

VL - 44

SP - 1209

EP - 1213

JO - Antimicrobial Agents and Chemotherapy

JF - Antimicrobial Agents and Chemotherapy

SN - 0066-4804

IS - 5

ER -